CYP17 polymorphism in the groups of distinct breast cancer susceptibility: Comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women

Cancer Letters

Volumn 156, Issue 1, 2000, Pages 45-50

  Kuligina, Ekatherina Sh ^a   Togo, Alexandr V ^a   Suspitsin, Evgeny N ^a   Grigoriev, Maxim Yu ^a   Pozharisskiy, Kazimir M ^a   Chagunava, Oleg L ^b   Berstein, Lev M ^a   Theillet, Charles ^c   Hanson, Kaido P ^a   Imyanitov, Evgeny N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b Center of Mammology   (Russian Federation)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Breast neoplasms; Cancer susceptibility; CYP17; Elderly; Polymorphism

Indexed keywords

STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE;

ADULT; AGE; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; LONGEVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STEROIDOGENESIS;

AGED; ALLELES; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0034257079     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00436-5     Document Type: Article

References (17)

1. Greene M.H. Genetics of breast cancer. Mayo Clin. Proc. 72:1997;54-65.
2. Goldman R., Shields P.G. Molecular epidemiology of breast cancer. In Vivo. 12:1998;43-48.
3. Dunning A.M., Healey C.S., Pharoah P.D., Teare M.D., Ponder B.A., Easton D.F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 8:1999;843-854.
4. Feigelson H.S., Coetzee G.A., Kolonel L.N., Ross R.K., Henderson B.E. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res. 57:1997;1063-1065.
5. Feigelson H.S., Shames L.S., Pike M.C., Coetzee G.A., Stanczyk F.Z., Henderson B.E. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res. 58:1998;585-587.
6. Haiman C.A., Hankinson S.E., Spiegelman D., Colditz G.A., Willett W.C., Speizer F.E., Kelsey K.T., Hunter D.J. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res. 59:1999;1015-1020.
7. Dunning A.M., Healey C.S., Pharoah P.D., Foster N.A., Lipscombe J.M., Redman K.L., Easton D.F., Day N.E., Ponder B.A. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br. J. Cancer. 77:1998;2045-2047.
8. Weston A., Pan C.F., Bleiweiss I.J., Ksieski H.B., Roy N., Maloney N., Wolff M.S. CYP17 genotype and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 7:1998;941-944.
9. Helzlsouer E.J., Huang H.Y., Strickland P.T., Hoffman S., Alberg A.J., Comstock G.W., Bell D.A. Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol. Biomarkers Prev. 7:1998;945-949.
10. Nedelcheva Kristensen V., Haraldsen E.K., Anderson K.B., Lonning P.E., Erikstein B., Karesen R., Gabrielsen O.S., Borresen-Dale A.L. CYP17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1. Cancer Res. 59:1999;2825-2828.
11. Huang C.S., Chern H.D., Chang K.J., Cheng C.W., Hsu S.M., Shen C.Y. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res. 59:1999;4870-4875.
12. Bergman-Jungestrom M., Gentile M., Lundin A.C., Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int. J. Cancer. 84:1999;350-353.
13. Comings D.E. Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. Alcohol. 16:1998;61-70.
14. Mullenbach R., Lagoda P.J., Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 5:1989;391.
15. Pomerantz R.A., Murad T., Hines J.R. Bilateral breast cancer. Am. Surg. 55:1989;441-444.
16. Graham M.D., Yelland A., Peacock J., Beck N., Ford H., Gazet J.C. Bilateral carcinoma of the breast. Eur. J. Surg. Oncol. 19:1993;259-264.
17. Ries L.A.G., Kosary C.L., Hankey B.F., Harras A., Miller B.A., Edwards B.K. SEER Cancer Statistics Review, 1973-1993: Tables and Graphs. 1996;National Cancer Institute, Bethesda.